Gabriela Plesa

Also affiliated with Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia University

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Cytokine-mediated CAR T therapy resistance in AML”.

Cytokine-mediated CAR T therapy resistance in AML

Nature Medicine(2024)10.1038/s41591-024-03271-5

N/A

2.2DataRank · unranked

90 citations

Leonel Torres, Olga Shestova, Maksim Shestov, Patrick Mellors, Han R Fisher +24 more

Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0486

N/A

2.2DataRank · unranked

95 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

Phase I trial of autologous cMET-directed CAR-t cells administered intravenously in patients with melanoma & breast carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10035

N/A

0.470DataRank · unranked

22 citations

Alexander C. Huang, Xiaowei Xu, Paul J. Zhang, Robert Orlowski, Tina Matlawski +15 more

Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102301

N/A

0.429DataRank · unranked

14 citations

Charly R. Good, Julie S. Barber-Rotenberg, Sangya Agarwal, Wesley V. Wilson, Alex Watts +27 more

B‐cell maturation antigen chimeric antigen receptor T‐cell re‐expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor‐based combination therapy

British Journal of Haematology(2021)10.1111/bjh.17397

N/A

0.373DataRank · unranked

11 citations

Lifeng Tian, Alfred L. Garfall, J. Joseph Melenhorst, Simon F. Lacey, Edward A. Stadtmauer +10 more

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells

Immunity(2023)10.1016/j.immuni.2023.09.001

N/A

0DataRank · unranked

171 citations

M. Ángela Aznar, Andrew J. Rech, Charly R. Good, Shunichiro Kuramitsu, Tong Da +15 more

Data from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T cells Administered Intravenously in Patients with Melanoma & Breast Carcinoma

(2023)10.1158/2767-9764.c.6547846.v1

N/A

0DataRank · unranked

0 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

Data from Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma

(2023)10.1158/2767-9764.c.6547846.v2

N/A

0DataRank · unranked

0 citations

Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter +20 more

Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals

Molecular Therapy(2020)10.1016/j.ymthe.2020.11.007

N/A

0DataRank · unranked

6 citations

Julie K. Jadlowsky, Simon F. Lacey, Joseph A. Fraietta, Gabriela Plesa, Hideto Chono +11 more

Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy

Cell stem cell(2024)10.1016/j.stem.2024.11.010

N/A

0DataRank · unranked

88 citations

Xin Wang, Yusha Sun, Stephen Bagley, Nannan Li, Arati Desai +11 more

Rapid manufacturing of non-activated potent CAR T cells

Nature Biomedical Engineering(2022)10.1038/s41551-021-00842-6

N/A

0DataRank · unranked

289 citations

Joseph S. Durgin, Selene Nuñez-Cruz, Jai Patel, John Leferovich, Marilia Rita Pinzone +11 more

Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer

Molecular Therapy(2020)10.1016/j.ymthe.2020.07.017

N/A

0DataRank · unranked

56 citations

Alexander C. Jordan, Evan Tooker, Simon F. Lacey, Renee B. Chang, Yan Li +11 more